ResearchFamily history of premature atherosclerotic cardiovascular disease and lipoprotein(a) levels: a multicohort analysis
ResearchThe role of inflammation in longitudinal renal function decline and incident chronic kidney disease: the multi-ethnic study of atherosclerosis
ResearchPopulation estimates, trends, characteristics and prognostic outcomes of cardiovascular-kidney-liver-metabolic health: A population-based study
Feb 11, 2026Journal ArticleLipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank.Written by 1 Roon author & 12 others Via The American Heart Association Journals
Feb 20, 2026Journal ArticleCirculating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank.Written by 1 Roon author & 10 others Via The American Heart Association Journals
ResearchLong-term prognosis of coexistent metabolic dysfunction-associated steatotic liver disease and chronic kidney disease following acute myocardial infarction
ResearchEditorial commentary: From prevalence to practice - implementing familial hypercholesterolemia screening in high-risk clinics using an implementation science framework
ResearchBody weight categories and fat distribution in relation to all-cause mortality among adults with metabolic dysfunction-associated steatotic liver disease: a population-based analysis of NHANES, 2007-2018
ResearchCommentary - genetic susceptibility as a risk enhancer in secondary prevention: Contextualizing the CAD polygenic risk score
ResearchAssociation of Lipoprotein(a) with cardiovascular events among individuals with autoimmune conditions
ResearchWhy, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications